What We Are Building Next.
Expanding beyond dairy-derived ingredients into specialty chemical API manufacturing, backed by in-house R&D and academic partnerships.
The Next Chapter
Lactitol India is currently developing a dedicated specialty chemical API manufacturing capability through plant segregation and an in-house R&D setup. This expansion is backed by academic joint ventures for clinical validation and reflects our commitment to building a future-ready ingredient portfolio.
CRAMS capabilities are available now for early-stage and custom manufacturing requirements. We believe a manufacturing company's impact extends well beyond its products. Our facility in Derabassi operates as a responsible neighbour to surrounding communities, not just a production site.
CRAMS capabilities are available now for early-stage and custom manufacturing requirements. We believe a manufacturing company's impact extends well beyond its products. Our facility in Derabassi operates as a responsible neighbour to surrounding communities, not just a production site.
Three Capability Blocks
R&D
In-House R&D Active development of new molecules and process optimisation within our own facility, not outsourced.
Clinical Partnerships
Academic JV Clinical-stage validation backed by partnerships with academic research institutions.
CRAMS
CRAMS Contract Research and Manufacturing Services for custom ingredient requirements, from bench to batch.
